UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
Cognizant
CTSH
|
+$150M |
| 4 |
Chubb
CB
|
+$107M |
| 5 |
Under Armour
UAA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$221M |
| 2 |
Workday
WDAY
|
+$133M |
| 3 |
Pfizer
PFE
|
+$122M |
| 4 |
Apple
AAPL
|
+$122M |
| 5 |
Nike
NKE
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 14.7% |
| 3 | Financials | 13.4% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VA
2176
DELISTED
Virgin America Inc.
VA
| $289K | ﹤0.01% |
7,500
-1,200
| -14% | -$37.4K |
|
|
AAIC
2177
DELISTED
Arlington Asset Investment Corp.
AAIC
| $287K | ﹤0.01% |
22,900
+7,117
| +45% | +$85.9K |
|
|
LION
2178
DELISTED
Fidelity Southern Corporation
LION
| $287K | ﹤0.01% |
17,900
| – | – |
|
2179
McGrath RentCorp
MGRC
$2.97B
| $286K | ﹤0.01% |
11,400
-900
| -7% | -$22.1K |
|
|
GNCMA
2180
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $286K | ﹤0.01% |
15,598
-2,100
| -12% | -$38.4K |
|
2181
Paylocity
PCTY
$8.04B
| $285K | ﹤0.01% |
8,700
| – | – |
|
|
LBAI
2182
DELISTED
Lakeland Bancorp Inc
LBAI
| $285K | ﹤0.01% |
28,120
| – | – |
|
|
INSY
2183
DELISTED
Insys Therapeutics, Inc.
INSY
| $285K | ﹤0.01% |
17,800
-1,500
| -8% | -$28.5K |
|
|
ADPT
2184
DELISTED
Adeptus Health Inc
ADPT
| $284K | ﹤0.01% |
5,116
-200
| -4% | -$10.3K |
|
2185
Pacific Biosciences
PACB
$363M
| $282K | ﹤0.01% |
33,146
-20,600
| -38% | -$203K |
|
2186
Photronics
PLAB
$1.88B
| $282K | ﹤0.01% |
27,096
-12,600
| -32% | -$136K |
|
|
EIGI
2187
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $282K | ﹤0.01% |
26,800
-3,200
| -11% | -$31.6K |
|
2188
Heritage Insurance Holdings
HRTG
$1.07B
| $281K | ﹤0.01% |
17,600
-1,500
| -8% | -$27.4K |
|
|
DX
2189
Dynex Capital
DX
$3.18B
| $280K | ﹤0.01% |
14,029
-3,737
| -21% | -$69.8K |
|
2190
Mistras Group
MG
$498M
| $280K | ﹤0.01% |
11,299
-400
| -3% | -$8.85K |
|
2191
Mercury Systems
MRCY
$6.53B
| $280K | ﹤0.01% |
13,798
-1,300
| -9% | -$22.7K |
|
|
BMTC
2192
DELISTED
Bryn Mawr Bank Corp
BMTC
| $280K | ﹤0.01% |
10,900
| – | – |
|
|
XLRN
2193
DELISTED
Acceleron Pharma
XLRN
| $280K | ﹤0.01% |
10,600
-162,624
| -94% | -$4.73M |
|
|
BKS
2194
DELISTED
Barnes & Noble
BKS
| $280K | ﹤0.01% |
22,681
-28,632
| -56% | -$280K |
|
|
ELGX
2195
DELISTED
Endologix Inc
ELGX
| $278K | ﹤0.01% |
3,330
-1,383
| -29% | -$114K |
|
|
REV
2196
DELISTED
Revlon, Inc.
REV
| $277K | ﹤0.01% |
7,600
| – | – |
|
|
IPHS
2197
DELISTED
Innophos Holdings, Inc.
IPHS
| $275K | ﹤0.01% |
8,899
-1,100
| -11% | -$30.3K |
|
2198
Angi Inc
ANGI
$201M
| $274K | ﹤0.01% |
3,390
-1,560
| -32% | -$135K |
|
2199
Stride
LRN
$3.32B
| $274K | ﹤0.01% |
27,699
-1,900
| -6% | -$18K |
|
2200
Encore Capital Group
ECPG
$2.08B
| $273K | ﹤0.01% |
10,599
-1,100
| -9% | -$25.4K |
|
Similar funds
UBS AM's Q1 2016 Portfolio in Review
As of Q1 2016, UBS AM held 2,740 positions worth $86.2B, down 1.7% from $87.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q1 2016 filing shows 51 new, 583 increased, 1,774 reduced and 113 closed positions. Its largest new stake was NXP Semiconductors: 1,291,575 shares worth $105M. The largest sale was Thermo Fisher Scientific, an estimated $221M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q1 2016 buy was NXP Semiconductors: 1,291,575 shares worth $105M.
- UBS AM added most to Alibaba in Q1 2016, an estimated $235M increase.
- UBS AM's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $221M.
- UBS AM fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $97.5M.
- UBS AM's ten largest holdings make up 15% of its $86.2B portfolio in Q1 2016.
- UBS AM opened 51 new positions and closed 113 in Q1 2016.
- UBS AM's portfolio value fell 1.7% quarter-over-quarter to $86.2B.
Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.